Botanical species · safety record
Vicia sativa
The EFSA Compendium of Botanicals holds 13 constituent measurements and 8 adverse-effect records for Vicia sativa. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.
Accepted name in source: Vicia sativa L.
Regulatory presence
No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.
What the records describe
Constituents measured
- Beta-cyano-l-alanine5
- Gamma-glutamyl-beta-cyanoalanine2
- 4-amino-butyric acid1
- Alkaloids1
- Cyanogenic glycosides1
- Ethanolamine1
- Hydrocyanic acid1
- Vicianin1
Plant parts
- Seed16
- Live plants3
- Leaves1
Preparations
- Solvent extraction9
- Raw, no heat treatment3
Effect types
- Neurotoxicity3
- Hepatotoxicity2
- Systemic2
- Reproductive1
Target tissues
- Neurologic3
- Liver2
- Urogenital1
Recorded constituents
What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.
| Substance | Plant part | Preparation | Concentration | Analytical method | Source |
|---|---|---|---|---|---|
| Beta-cyano-l-alanine | Seed | Solvent extraction | ≤ 0.03 Percent | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Beta-cyano-l-alanine | Seed | Solvent extraction | ≥ 0.01 Percent | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Beta-cyano-l-alanine | Seed | — | 0.93 Percent | Colorimetry, Spectroscopy (Spectrometry) and Photometry | Resolve DOI |
| Cyanogenic glycosides | Seed | Solvent extraction | — | HPLC-DAD | Resolve DOI |
| Ethanolamine | Leaves | Solvent extraction | 6.6 Microgram/gram | HPLC-DAD | Resolve DOI |
| Gamma-glutamyl-beta-cyanoalanine | Seed | Solvent extraction | ≤ 0.74 Percent | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Gamma-glutamyl-beta-cyanoalanine | Seed | Solvent extraction | ≥ 0.42 Percent | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Vicianin | Seed | — | — | — | Resolve DOI |
| 4-amino-butyric acid | Seed | Solvent extraction | — | — | No resolvable identifier |
| Alkaloids | Seed | Raw, no heat treatment | — | Unspecified | No resolvable identifier |
| Beta-cyano-l-alanine | Seed | Solvent extraction | ≥ 0.09 Percent | UV/VIS spectroscopy (photometry) | No resolvable identifier |
| Beta-cyano-l-alanine | Seed | Solvent extraction | ≤ 0.15 Percent | UV/VIS spectroscopy (photometry) | No resolvable identifier |
| Hydrocyanic acid | Seed | Raw, no heat treatment | 64.8 Milligram/100 gram | Unspecified | No resolvable identifier |
Recorded adverse effects
Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.
| Effect | Target tissue | Plant part | Preparation | Test organism | Test type | Source |
|---|---|---|---|---|---|---|
| Reproductive | Urogenital | Live plants | — | Cattle (as animal) | Case report | Resolve DOI |
| Systemic | — | Seed | — | Gallus gallus (chicken) (as animal) | Short-term toxicity | Resolve DOI |
| Hepatotoxicity | Liver | Live plants | — | Pig (as animal) | Case report | No resolvable identifier |
| Hepatotoxicity | Liver | Live plants | — | Horse (as animal) | Case report | No resolvable identifier |
| Neurotoxicity | Neurologic | Seed | — | Rhesus monkey (as animal) | Not reported | No resolvable identifier |
| Neurotoxicity | Neurologic | Seed | — | Duck (as animal) | Not reported | No resolvable identifier |
| Neurotoxicity | Neurologic | — | — | Rat (as animal) | Acute toxicity | No resolvable identifier |
| Systemic | — | Seed | Raw, no heat treatment | Rabbit (as animal) | Case report | No resolvable identifier |
Cited sources
The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.
- Ressler, C., Tatake, JG., Kaizer, E., Putnam, DH. Neurotoxins in a vetch food: Stability to cooking and removal of gamma-glutamyl-beta-cyanoalanine and beta-cyanoalanine and acute toxicity from common vetch (Vicia sativa L) legumes . Journal of agricultural and food chemistry, 1997, vol. 45, no. 1, p. 189-194. DOI
- Steyn, D. G. Poisoning of human beings by weeds contained in cereals (bread poisoning). Onderstepoort journal of veterinary research, 1933, vol. 1, p. 219-66.
- Ressler, C., Tatake, JG. Vicianin, prunasin, and beta-cyanoalanine in common vetch seed as sources of urinary thiocyanate in the rat . Journal of agricultural and food chemistry, 2001, vol. 49, no. 10, p. 5075-5080. DOI
- Suter, RJ. Suspected cyanide poisoning in cows fed vetch (Vicia sativa) hay. Australian veterinary journal, 2002, vol. 80, no. 5, p. 282-282. DOI
- RESSLER, C. ISOLATION AND IDENTIFICATION FROM COMMON VETCH OF NEUROTOXIN BETA-CYANO-L-ALANINE, A POSSIBLE FACTOR IN NEUROLATHYRISM . Journal of biological chemistry, 1962, vol. 237, no. 3, p. 733-&.
- Berger, JD., Robertson, LD., Cocks, PS. Agricultural potential of Mediterranean grain and forage legumes: 2) Anti-nutritional factor concentrations in the genus Vicia . Genetic resources and crop evolution, 2003, vol. 50, no. 2, p. 201-212. DOI
- Ahn, Young Ock., Saino, Hiromichi., Mizutani, Masaharu., Shimizu, Bun-ichi., Sakata, Kanzo. Vicianin hydrolase is a novel cyanogenic beta-glycosidase specific to beta-vicianoside (6-O-alpha-l-arabinopyranosyl-beta-d-glucopyranoside) in seeds of Vicia angustifolia . Plant and cell physiology, 2007, vol. 48, no. 7, p. 938-947. DOI
- Kamo, Tsunashi., Tokuoka, Yoshinori., Miyazaki, Masahisa. Quantification of Canavanine, 2-Aminoethanol, and Cyanamide in Aphis craccivora and its Host Plants, Robinia pseudoacacia and Vicia angustifolia: Effects of These Compounds on Larval Survivorship of Harmonia axyridis . Journal of chemical ecology, 2012, vol. 38, no. 12, p. 1552-1560. DOI
Boundary
A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.
Continue
Europe PMC
Every record indexed for this species, resolvable and re-runnable.
All speciesSubstance index
Search and browse every species this world holds under source and hash.
Before anything elseSafety Centre
Interactions, contraindications and the escalation boundary this world does not cross.
In its own termsTraditions
How the living traditions approach preparation, use and context.